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ABSTRACT
The inherent behavioral variability exhibited by stochastic biochemical systems makes it a challenging
task for human experts to manually analyze them. Computational modeling of such systems helps in
investigating and predicting the behaviors of the underlying biochemical processes but at the same
time introduces the presence of several unknown parameters. A key challenge faced in this scenario
is to determine the values of these unknown parameters against known behavioral specifications. The
solutions that have been presented so far estimate the parameters of a given model against a single
specification whereas a correct model is expected to satisfy all the behavioral specifications when
instantiated with a single set of parameter values. We present a new method, BioMETA, to address
this problem such that a single set of parameter values causes a parameterized stochastic biochemical
model to satisfy all the given probabilistic temporal logic behavioral specifications simultaneously.
Our method is based on combining a multiple hypothesis testing based statistical model checking
technique with simulated annealing search to look for a single set of parameter values so that the
given parameterized model satisfies multiple probabilistic behavioral specifications. We study two
stochastic rule-based models of biochemical receptors, namely, FcRI and T-cell as our benchmarks
to evaluate the usefulness of the presented method. Our experimental results successfully estimate 26
parameters of FcRI and 29 parameters of T-cell receptor model against three probabilistic temporal
logic behavioral specifications each.
Keywords cell signaling; multiple hypothesis testing; parameter estimation; rule-based models; signal temporal logic;
statistical model checking; stochastic biochemical models; systems biology
1 Introduction
Stochastic rule-based models serve as a natural and compact representation for biochemical reactions. Biochemical
modeling languages [1, 2] are used to succinctly describe biochemical systems, such as cell signaling pathways. The
Gillespie stochastic simulation algorithm [3] and its variants [4] are then employed to predict the behavior of the
biochemical system modeled by the stochastic rule-based model.
However, it is often not feasible to create a complete stochastic rule-based model from first principles. Instead, our
knowledge of the biochemical system is used to obtain the set of chemical reactions or the core structure of the stochastic
rule-based model. The lack of knowledge about the rate constants of biochemical reactions is readily modeled as
unknown parameters in stochastic rule-based models.
A primary challenge in the use of such a parameterized stochastic rule-based model for predicting the behavior of
a biological system is the determination of the parameters of the model from multiple experimental observations.
Traditionally, parameter values of a stochastic model have been estimated against quantitative time series data. A few
relatively recent efforts [5, 6] have focused on estimating the parameters of a biological model against qualitative
stochastic experimental observations encoded as probabilistic temporal logic formulas.
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However, the focus of these efforts has been on discovering parameter values of a paramaterized stochastic biological
model from a single probabilistic temporal logic specification. In practice, a biological model must satisfy multiple
experimental observations made on the biological system being modeled. Hence, it is important to estimate a single
set of parameter values that causes a parameterized stochastic model to satisfy multiple probabilistic temporal logic
specifications simultaneously.
In this study, we make the following contributions towards parameter estimation of stochastic biochemical models:
(i) We design a new approach that utilizes a quantitative tightness metric to estimate a single set of parameter
values for a parameterized stochastic biochemical model such that the model satisfies all the given probabilistic
temporal logic behavioral specifications simultaneously. Our approach employs multiple hypothesis testing
based statistical model checking to evaluate stochastic models against multiple specifications. It further uses
simulated annealing search to estimate the unknown parameters present in the model.
(ii) Our experimental results demonstrate that our method BioMETA is able to estimate 26 parameters of the
FcRI model and 29 parameters of the T-cell receptor model satisfying three temporal logic properties each.
2 Background
In the following subsections, we first describe rule-based modeling using software tool BioNetGen [2]. We then
formally define Signal Temporal Logic (STL) [7] that is used to encode behavioral specifications as temporal logic
formulas. We also describe TeLEx [8] that computes the quantitative tightness metric describing how well the given
model satisfies a behavioral specification.
2.1 Rule-based modeling
Rule-based modeling is a relatively new formalism that allows to model biochemical systems by representing molecules
as structured objects and molecular interactions as rules [1, 9, 10, 11]. The interactions can be of various types including
associations, dissociations, modifications to the internal state of a molecule as well as the production or consumption of
molecular species [12]. In other words, a rule specifies how the states of reactants are modified to generate products
in a biochemical reaction. Molecular interactions can result in a large number (hundreds to thousands) of possible
molecular species. Conventional approaches, involving translating the model into ODEs or CTMCs, are unable to
handle such combinatorial complexity. Rule-based modeling addresses this problem by expressing models with a
high degree of modularity and avoid the explicit enumeration of all possible molecular species or all the states of a
system; hence, providing a succinct representation of the model [1]. The rules are then simulated to generate a reaction
network comprised of all chemically distinct species and reactions [2]. Therefore, a rule-based model is a compact and
generalized representation of conventional biochemical models.
2.2 BioNetGen software
Biological Network Generator (BioNetGen) is an open source software tool that can be used to construct, visualize,
simulate and analyze rule-based models. The tool is based on a formal language, known as BioNetGen language
(BNGL), for specifying molecules and rules to model biological systems. A BNGL model file is composed of six primary
blocks [13], namely, (i) parameters that include rate constants and values for initial concentrations of species and are
responsible for governing the dynamics of the system, (ii) molecule types defining molecules, including components
and allowed component states, (iii) seed species that describe the initial state of the system, (iv) observables that
output functions of concentrations of species having particular attributes, (v) reaction rules describing how molecules
interact with each other and (vi) actions that provide various methods for generating and simulating the network. In our
experiments, we use the stochastic simulation algorithm (SSA) implemented in the software to simulate our biochemical
models. Each model simulation results in a time-stamped simulation trace capturing the behavior of the model when
instantiated with a particular set of parameter values.
2.3 Signal Temporal Logic and TeLEx
It is required that the acceptable behaviors of a model are represented as temporal logic formulas so that computational
methods can be applied to verify whether a model satisfies a behavior or not. In this study, we use Signal Temporal
Logic (STL) to encode the known behaviors of a stochastic biochemical model. It is a linear time temporal logic used
to represent continuous time behaviors of a model [14, 7]. We use a time bounded variant of STL where all temporal
operators are associated with a lower and upper time-bound. The logical operators in STL formulas consist of ∧ (and),
∨ (or), ¬ (negation), and bounded time operators consist of G (global), F (future), and U (until).
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Definition 1 (Signal Temporal Logic). A Signal Temporal Logic formula representing a model’s known behavior is
defined recursively by the following grammar:
φ := µ | ¬µ | φ1 ∧ φ2 | φ1 ∨ φ2 | G[t1,t2] φ | F[t1,t2] φ | φ1 U[t1,t2] φ2
where φ, φ1 and φ2 are STL formulas, 0 6 t1 < t2 <∞ and µ is a predicate whose value is determined by the sign of a
function of an underlying signal x ∈ R, i.e., µ ≡ µ(x) > 0 [14, 8]. In this study, signal x is termed as a simulation trace
or simulation trajectory and is obtained by simulating a given model in BioNetGen software. The validity of a formula
φ with respect to signal x at time t is defined inductively as follows:
(x, t)  µ ⇔ µ(xt) > 0
(x, t)  ¬µ ⇔ ¬((x, t)  µ)
(x, t)  φ1 ∧ φ2 ⇔ (x, t)  φ1 ∧ (x, t)  φ2
(x, t)  φ1 ∨ φ2 ⇔ (x, t)  φ1 ∨ (x, t)  φ2
(x, t)  G[t1,t2]φ ⇔ ∀t′ ∈ [t+ t1, t+ t2] s.t.(x, t′)  φ
(x, t)  F[t1,t2]φ ⇔ ∃t′ ∈ [t+ t1, t+ t2] s.t.(x, t′)  φ
(x, t)  φ1U[t1,t2]φ2 ⇔ ∃t′ ∈ [t+ t1, t+ t2] s.t.(x, t′)  φ2
∧ ∀t′′ ∈ [t, t′], (x, t′′)  φ1
A signal x satisfies φ, denoted by x  φ, if (x,0)  φ. Informally, x  G[t1,t2]φ if φ holds at every time step between
t1 and t2, and x  F[t1,t2]φ if φ holds at some time step between t1 and t2. Also, x  φ1U[t1,t2]φ2 if φ1 holds at every
time step before φ2 holds, and φ2 holds at some time step between t1 and t2.
Due to the stochastic nature of the given biochemical models, their behavioral specifications are also often probabilistic
in nature. Therefore, we use a probabilistic variant of Signal Temporal Logic to encode model behaviors. Probabilistic
STL can be further explained with the help of following example:
Example 1. Consider the following probabilistic Signal Temporal Logic formula:
P≥0.85(G[0,100]((GProtein > 6000) ∧ F[100,200](GProtein < 6000)))
It says that G protein should always have a high value i.e. greater than 6000 units during the first 100 (0-100) time
units and should fall below 6000 at some point in time during the next 100 (100-200) time units with a probability of at
least 0.85.
To verify the model against a given STL property we use the algorithm implemented by a software framework Temporal
Logic Extractor (TeLEx) [8]. Given a time-stamped simulation trace and a STL behavioral specification formula, TeLEx
quantifies the degree of model satisfiability by computing a tightness metric that describes how well a model satisfies the
specification. TeLEx uses smooth functions, such as sigmoid and exponentials, to compute tight-satisfiability of STL
formulas. A successful simulation trajectory of a model refers to such a trajectory that satisfies a given STL formula.
Whereas an unsuccessful simulation trajectory refers to a trajectory that does not satisfy the given STL formula. TeLEx
returns a positive value in case the STL formula is verified successfully; the larger the value the better it satisfies the
behavior. If the model is not able to satisfy the STL formula, the algorithm returns a negative value describing how far
off is the model from satisfying the specification; for further details and examples see [8].
3 Related Work
One of the crucial steps in the process of parameter estimation is to check the model against behavioral temporal logic
specifications. Statistical Model Checking (SMC) [15] is a popular method among many well-studied model checking
techniques available in the literature. A detailed survey [16] on various SMC techniques indicates that Statistical Model
Checking based on Wald’s Sequential Probability Ratio Test (SPRT) [17] is widely studied [18, 19, 20] and used in
practice. Another variant of SMC [21, 6] uses Bayesian Sequential Hypothesis Testing and improves performance by
incorporating prior knowledge about the model being verified. Mancini et al. [22] propose a parallel SMC algorithm to
yield model parameters of biological systems represented as Ordinary Differential Equations (ODEs). Their approach
follows a master-slave architecture where a single master implements the SMC algorithm and assigns the numerical
integration of the given ODE system to slaves.
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Satisfiability Modulo Theory (SMT) has also been used to perform model checking of biological models [23]. It works
by first extracting a collection of ODEs from a given model and then formulating these ODEs along with time-series
data into a collection of SMT problems. Another approach [5] performs model checking based on an open source
symbolic model checker, NuSMV [24], and formulates a given model using Binary Decision Diagrams (BDDs). These
BDDs provide a compact way of representing boolean functions which in turn represent the different states of the given
model.
A recent study [12] presents a SMC based parameter estimation framework for rule-based models formulated in
BioNetGen. It verifies experimental data as well as qualitative properties of the given model. Wang et al. [25] extends
the rule-based BioNetGen language to enable the specification of interactions among more than one cell. They employ
SMC in order to analyze system properties and obtain interesting insights into the development of novel therapeutic
strategies for pancreatic cancer. Techniques based on applying convolutional neural networks [26] in order to learn
temporal formulas have also been recently proposed.
However, each of these methods is limited to verifying the model with a binary (yes/no) outcome whereas we compute
a quantitative tightness metric describing how well the given model satisfies a behavioral specification. Further, these
methods are limited to verifying only a single temporal logic property of the model at one time whereas BioMETA uses
a sequential multiple hypothesis testing technique to validate the model against all given specifications simultaneously.
3.1 Approaches using a quantitative measure to check model satisfiability
Several attempts have been made to estimate parameters of stochastic systems using a quantitative measure of how well
a model satisfies a known temporal logic behavioral specification.
Rizk et al. [27] define a continuous degree of satisfaction of a temporal logic property which is then used as a fitness
function in order to find kinetic parameters of a biochemical model. However, their continuous degree of satisfaction
is limited to providing a quantitative measurement only in case of dissatisfaction and remains zero in case the model
satisfies a temporal logic property. Whereas we compute a tightness metric that provides a quantitative measure
irrespective of whether or not the model satisfies a system property; thus, giving a more meaningful interpretation of
model verification.
Another technique [28] using Gaussian Process Upper Confidence Bound (GP-UCB) computes a distribution of a
quantitative satisfaction function specifying the degree of satisfaction of a property by the model. An average of this
distribution is later used to guide the parameter search. However, this approach is limited to verifying only one temporal
logic property at one time as opposed to BioMETA’s ability to verify all the properties simultaneously.
A global exploration of the parameter space of stochastic biochemical systems is performed using probabilistic model
checking [29, 30, 31]. For each parameter point, they compute approximate upper and lower bounds of a landscape
function that returns a quantitative value. This value is based on the probability that the model satisfies a given
CSL (continuous stochastic logic) formula. Another software framework uses the Bayesian formalism for parameter
estimation and model selection [32]. Euclidean distance (sum of squares) between the observed data and a simulated
trajectory is computed; a parameter point is accepted if this distance is less than a threshold value.
To the best of our knowledge, this is the first time that a quantitative tightness metric is used to check model satisfiability
against multiple probabilistic temporal logic behavioral specifications simultaneously; hence, generating a single set of
parameter values.
4 Our Approach
We are interested in finding a set of parameter values ρ0 ∈ Rn so that the modelM, when instantiated with set ρ0,
satisfies each specification φi with probability greater than or equal to its corresponding required probability ri. We
now formally define our problem.
Definition 2 (Multiple specification parameter estimation problem). Given a parameterized stochastic rule-based
modelM(ρ) with parameter set ρ ∈ Rn, a set of desired specifications φ = {φ1, ..., φk} in Signal Temporal Logic, and
a corresponding set of required probabilities r = {r1, ..., rk} where ri ∈ [0,1], find a set of parameter values ρ0 such
that the following holds:
M(ρ0)  P≥r1(φ1) ∧ P≥r2(φ2) ∧ · · · ∧ P≥rk(φk)
Our solution to the problem of estimating parameters from multiple specifications is illustrated in Figure 1. Given
an initial set of parameter values ρinit, we first simulate the given modelM(ρinit) using BioNetGen to generate a
time-stamped simulation trace. The simulation trace along with the given set of k STL specifications φ = {φ1, ..., φk} is
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then fed to TeLEx which returns k quantitative tightness metrics describing the distance between the modelM(ρinit)
and each of the k given specifications. TeLEx quantitative tightness metrics and the set of required probabilities r =
{r1, ..., rk} are then passed onto multiple hypothesis testing (MHT) that decides whether the model instantiated with
ρinit satisfies the given probabilistic STL specifications or not. The hypothesis test continues on drawing samples, i.e.
continues on generating model simulations, until it has made a decision. If the test declares thatM(ρinit) satisfies all
the given specifications with greater than or equal to their corresponding required probabilities, then ρinit is returned
as the estimated set of parameter values. Otherwise a search algorithm, guided by the mean of quantitative tightness
metrics, explores the parameter space of the given model in order to find a new set of parameter values and repeats the
above process.
Figure 1: Our proposed method: BioMETA. A Multiple specification parameter estimation system using multiple
hypothesis testing based statistical model checking.
We explain the approach implemented in this study by dividing it into two phases. The first phase employs multiple
hypothesis testing (MHT) based statistical model checking to check a given model against multiple STL behavioral
specifications. The second phase of our method implements a simulated annealing based search algorithm to explore
model’s parameter space and finds a single set of parameter values which satisfies all the given probabilistic behavioral
specifications simultaneously.
4.1 Multiple hypothesis testing based model checking
As the problem (Definition 2) states, given a set φ of k STL behavioral specifications we are required to generate a
single set of parameter values such that the model satisfies each specification φi with probability at least ri. In order to
achieve this, the given model is first simulated using BioNetGen and the simulation trace is verified using TeLEx against
each given specification. Essentially, TeLEx verification function is called k times and each call returns a quantitative
tightness metric against the respective specification φi.
Due to the stochastic nature of the given model, model simulations with the same parameter values show varying
behaviors which results in varying TeLEx tightness metrics. Therefore a multiple hypothesis testing technique, proposed
by Bartroff et al. [33], is employed that generates several model simulations before deciding model satisfiability. The
process of generating multiple simulations results in forming a separate distribution of TeLEx tightness metrics against
each specification. Hence, k distributions are generated where each distribution corresponds to the tightness metrics
computed by TeLEx against each of the k STL specifications.
We define the mean of each distribution i as θ(i). In order to decide whether the given model satisfies a specification,
we aim to test the hypothesis that the mean θ(i) of each distribution is less than a threshold value θ′(i) [17, Section 5.4].
If the mean θ(i) of distribution i is greater than its corresponding threshold θ′(i), the model satisfies φi since a greater
mean of TeLEx tightness metrics indicates better model satisfiability. However if θ(i) < θ′(i), it is considered that the
model does not satisfy the corresponding specification φi.
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Instead of testing the hypothesis against a single value θ′(i), the problem is relaxed by introducing two thresholds θ(i)0
and θ(i)1 such that θ
(i)
0 < θ
′(i) < θ(i)1 . We vary the two thresholds using a common factor, δ i.e. θ
(i)
0 = θ
′(i) − δ and
θ
(i)
1 = θ
′(i) + δ where 0 < δ < 1 [34]. The region (θ(i)0 , θ
(i)
1 ) is defined as the indifference region. As the indifference
region becomes smaller, we reduce the risk of making a wrong decision but this comes at the cost of drawing more
samples in order for the hypothesis test to make a decision. Hence for each distribution i, we test the following
hypothesis:
H
(i)
0 : θ
(i) = θ
(i)
0
H
(i)
1 : θ
(i) = θ
(i)
1
(1)
with type I (false negative) and type II (false positive) family-wise error rate (FWER) bounds as α and β respectively.
Suppose x(i)j is the tightness metric returned by TeLEx after verifying j
th simulation trace against ith STL specification
φi. Then for the nth model simulation, the hypothesis test calculates the following log-likelihood ratio against each
specification φi:
Zi = log
e−(1/2σ
2
i )
∑n
j=1(x
(i)
j −θ(i)1 )2
e−(1/2σ
2
i )
∑n
j=1(x
(i)
j −θ(i)0 )2
(2)
The test samples sequentially until Zi ≤ Ai or Zi ≥ Bi where Ai and Bi are the stopping boundaries and are defined
as functions of FWER bounds α and β. For each distribution i, the stopping boundaries are defined as:
Ai = log
(
β
(1− αi)(k − i+ 1)
)
, Bi = log
(
(1− βi)(k − i+ 1)
α
)
(3)
where,
αi =
(k − i+ 1− β)α
(k − i+ 1)(k − β) , βi =
(k − i+ 1− α)β
(k − i+ 1)(k − α) (4)
Note that the hypothesis test continues on taking samples until each Zi crosses one of its corresponding stopping
boundaries Ai or Bi.
Rejection of the null hypothesis H(i)0 indicates that the mean of the distribution i is greater than threshold θ
′(i) and
model satisfies the corresponding behavioral specification φi whereas, acceptance of a null hypothesis H
(i)
0 means that
the model with its current set of parameter values is not able to satisfy φi. In case all H
(i)
0 are rejected, BioMETA
further checks whether each specification φi is satisfied with probability at least ri. If yes, BioMETA returns the current
set of parameter values as the solution otherwise, it explores other parameter values using our search algorithm. We
describe the behavior of the search algorithm in the following subsection.
4.2 Parameter search algorithm
To explore the parameter space of the given model, we employ an iterative search algorithm known as simulated
annealing. It is a probabilistic technique for approximating the global optimum of a given function. The algorithm
(refer to Algorithm 1) starts the search at a high temperature value, ti, provided as input (line 1). It then generates a
random set of parameter values, ρinit, and checks model satisfiability against given specifications using our multiple
hypothesis testing (MHT) based statistical model checking approach (described in the previous subsection) (lines 2-3).
ρinit is returned as the estimated set of parameter values in case the hypothesis test returns “accept" which indicates that
the modelM(ρinit) satisfies all given specifications (line 4). If the hypothesis test rejects ρinit, the algorithm generates
a new neighboring set of parameter values, ρnew, by slightly perturbing the previous parameter set, and again checks
model satisfiability with ρnew. Every time a parameter set is rejected, the algorithm starts a new iteration by finding a
neighboring parameter set and repeating the model checking step (lines 7-21).
The objective function that drives the search algorithm is defined as the mean of unsuccessful simulations exhibiting
negative TeLEx tightness metrics. For each new iteration, mean (µnew) of the current iteration is compared with mean
(µold) of the previous iteration and the parameter set that is maximizing the mean function is accepted. However, in
order to avoid local optima the algorithm also sometimes, with a very small probability, accepts bad solutions i.e.
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accepts parameter set with smaller means (lines 14-18). As the current temperature t goes down, based on a cooling
factor c (line 20), the probability of accepting bad solutions also decreases in order for the algorithm to achieve stability.
Once it finds a set of parameter values for which the model successfully satisfies all specifications with their respective
required probabilities, it stops and returns that parameter set. The algorithm continues until it finds the required set of
parameter values or the given temperature cools down to a predefined value, tf . In the later case, the algorithm returns
that it was unable to find the required parameter set (line 22). A python based implementation of Algorithm 1 can be
found at https://github.com/arfeenkhalid/parameter-synth.
Algorithm 1 BioMETA Algorithm: Multiple specification parameter estimation system.
Require:
M(ρ) Parameterized stochastic model
{φ1, φ2, ..., φk} STL specifications
{r1, r2, ..., rk} required probabilities
ti initial temperature
tf final temperature
c cooling rate
Ensure:
ρ0 such thatM(ρ0)  P≥r1(φ1) ∧ P≥r2(φ2) ∧ .... ∧ P≥rk(φk)
1: t← ti
2: ρinit ← rand( )
3: result, µinit← MHT(M(ρinit), {φ1, .., φk}, {r1, .., rk})
4: if result = “acc" then return ρinit end if
5: ρnew ← ρinit
6: µnew ← µinit
7: while t > tf do
8: ρold← ρnew
9: µold← µnew
10: ρnew ← FINDANEIGHBOUR(ρold)
11: result, µnew ← MHT(M(ρnew), {φ1, .., φk}, {r1, .., rk})
12: if result = “acc" then return ρnew
13: else
14: if µnew 6 µold then
15: if rand(0, 1) > e(−(µnew−µold)/t) then
16: ρnew ← ρold
17: end if
18: end if
19: end if
20: t← c ∗ t
21: end while
22: return “No parameter set found!”
5 Results and Discussion
We study two rule-based receptor models FcRI and T-cell for experimental purposes. We show that the presented
method BioMETA is successful in estimating 26 parameters of a FcRI model and 29 parameters of a T-cell model
satisfying three STL properties each. The next two subsections describe the models, discuss their respective STL
specifications and demonstrate our experimental results. All experiments were performed on an Intel Xeon Platinum
8160 48-Core 2.10 GHz processor with 768 GB of RAM operating under Ubuntu 16.04.6 LTS.
5.1 Benchmark 1: FcRI
FcRI is the high affinity receptor for immunoglobulin E (IgE) and is a member of the multichain immune recognition
receptors (MIRR) family. It is responsible for controlling the activation of two different types of white blood cells
known as human mast cells and basophils which are a crucial part of the immune and neuroimmune system in living
organisms. To be more specific, FcRI plays an important role in wound healing and immediate allergic reactions. It
also participates in antigen presentation of immediate hypersensitivity reactions involving IgE-mediated release of
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histamine and some other mediators. Some of these allergic reactions can result in serious consequences and FcRI
is of vital importance [35] in providing physiological protection against such reactions and maintaining the allergic
response by controlling the secretion of allergic mediators and induction of cytokine gene transcription.
We perform our experiments on a rule-based model of FcRI developed by Faeder et al. [36] which aims to examine
the function of multiple components in the phosphorylation and activation of Spleen tyrosine kinase, Syk, whose
inhibition aids in treating autoimmune diseases. The authors of [36] model FcRI in its tetrameric form, which includes
an α-chain that binds IgE and three Immunoreceptor Tyrosine-based Activation Motif (ITAM)-containing subunits, a
β-chain, and two disulfide-linked γ-chains. The model exhibits four major reactions namely association, dissociation,
phosphorylation, and dephosphorylation. All experiments in [36] are performed to stimulate and observe rat basophilic
leukemia (RBL) cells using covalently cross-linked IgE dimers.
We translate three important model behaviors described in the results section of [36] to the following probabilistic
Signal Temporal Logic behavioral properties:
Property 1:
P≥0.95(F[0,1500]((RecDim/RecTot > 0.5) ∧G[1500,3000](RecDim/RecTot > 0.5)))
The first property investigates the kinetics of receptor aggregation and tyrosine phosphorylation in RBL cells when
they are stimulated with covalently linked dimers of IgE. This property monitors one of the features of dimer-induced
receptor (RecDim) phosphorylation where the percentage of RecDim reaches half of its maximum value at around half
an hour of the simulation and keeps on increasing till one hour. In other words, this property verifies if the percentage
of RecDim is observed to persist in the later half of the simulation.
Property 2:
P≥0.80(F[0,1500]((LynRecPbeta/LynTot > 0.8) ∧G[1500,3000](LynRecPbeta/LynTot > 0.8)))
Simulating the FcRI model shows a rapid redistribution of Tyrosine-protein kinase Lyn. This redistribution becomes
even more tightly associated with the receptor via binding of Lyn’s SH2 domain to the phosphorylated β ITAM
(LynRecPbeta). The second property verifies if a large percentage (say 80%) of the available Lyn is bound through its
SH2 domain to β when the receptor aggregation reaches its maximum.
Property 3:
P≥0.99(G[1200,3000](RecPgamma/RecPbeta > 2.0))
Another observation made by the authors in [36] is that Syk, which binds to the γ ITAM, is present in much higher
concentration than Lyn, which binds to the β ITAM. This happens because a phosphorylated γ ITAM tyrosine has
a longer lifetime than a β phosphotyrosine. Our third property verifies this behavior by showing that the level of γ
phosphorylation (RecPgamma) exceeds that of β phosphorylation (RecPbeta) by ∼2-fold after simulating the model for
some time and persists this behavior afterwards. Figure 2 illustrates the successful traces obtained from BioNetGen
verifying the above three STL properties of FcRI model. For comparison purposes, this figure also shows some of the
unsuccessful traces obtained during the model checking phase.
Table 1 shows the estimated set of parameter values of FcRI satisfying all three specifications simultaneously obtained
by BioMETA when α = 0.005, β = 0.2 and r = {0.95, 0.80, 0.99}. As mentioned before there are two types of
parameters in rule-based models: initial concentration of species and rate constants. The first four parameters in Table 1
represent the molecules present in FcRI model and the values represent their initial concentration at the start of each
simulation. Parameters 5-26 are the rate constants which measure the rate at which a certain reaction rule proceeds. For
instance, parameter 17 (pLb) and 19 (pLg) act as the rate constants for receptor transphosphorylation of β and γ ITAMs
respectively by constitutive Lyn. The result of this transphosphorylation is being observed in Property 3 of FcRI model.
Each of the rate constants is able to regulate one or more reactions. For example, parameter 25 (dm) serves as a rate
constant for two reactions i.e. receptor dephosphorylation of β as well as γ ITAMs.
5.2 Benchmark 2: T-cell
Our second benchmark is a rule-based model of T-cell receptor, also known as T-lymphocyte. It is a type of white
blood cell that is a vital part of the immune system. It detects the presence of toxins or other foreign substances, known
as antigens, with the help of T-cell receptors (TCRs). The antigens trigger a living organism’s immune system to
produce anitbodies which in turn help protect the body against bacteria and viruses. The surface receptors TCRs bind
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Figure 2: Successful simulation trajectories (in blue) of FcRI model satisfying property 1, 2 and 3. Unsuccessful
trajectories against each of the above properties are shown in red.
Table 1: Estimated set of parameter values obtained by BioMETA for FcRI satisfying three specifications with r =
{0.95, 0.80, 0.99}, α = 0.005, β = 0.2
Param No. Param Name Param Value
1 Lig_tot 3.748e06
2 Rec_tot 582.79
3 Lyn_tot 0.5921
4 Syk_tot 1.772e05
5 kp1 1.90e-09
6 km1 1.507
7 kp2 4.1474
8 km2 0.0037
9 kpL 0.2603
10 kmL 0.5118
11 kpLs 0.3815
12 kmLs 0.00036
13 kpS 0.02757
14 kmS 0.0055
15 kpSs 0.5274
16 kmSs 0.00013
17 pLb 61.432
18 pLbs 13124.41
19 pLg 397.217
20 pLgs 0.1716
21 pLS 0.1181
22 pLSs 1453.91
23 pSS 10578.92
24 pSSs 5.3064
25 dm 0.06354
26 dc 73.245
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to some specific polypeptide fragments that are displayed, by a protein called the major histocompatibility complex
(MHC), on the surface of neighboring cells. T-cell is known to maintain a very intricate balance between exhibiting
strong responses to the presence of extremely small quantities of antigen while not responding to the large quantities
of host peptide-MHC (pMHC). By detecting antigens in this way, it is able to successfully avoid autoimmunity. This
characteristic along with some other attributes affiliated with the model, add an element of uncertainty to its dynamics
resulting in trajectories that may exhibit completely different behavior even though generated from the same initial state
[37]. Such a stochastic nature of this model makes it a challenging benchmark for our current study.
In order to avoid autoimmunity, T-cell receptor must ignore self peptides and at the same it must recognize foreign
peptides for immune defense. Thus, a correct T-cell model is expected to discriminate between agonist and antagonist
peptides [38]. In order to test this particular behavior, we observe the model’s primary output i.e. the fraction of
doubly phosphorylated ERK (ppERK). This fraction (ppERK/totERK) is also taken as a measure of T-cell activation.
If ppERK/totERK < 0.10, the cell is considered to be inactive and if ppERK/totERK > 0.50, the T-cell is
considered to be in its active state. All three of our properties closely observe the value of this fraction and determine if
the cell successfully achieves an active state after exhibiting an inactive state (and vice versa) within a defined period of
time. We estimate the parameter values of the model such that it satisfies the following three properties:
Property 1:
P≥0.85(G[0,300](ppERK/totERK < 0.95))
As mentioned earlier, cell activity is measured by changing the quantity of ppERK. The first property verifies if the
fraction of ppERK always stays below a given threshold value (0.95) during the first 300 time units of the simulation.
Property 2:
P≥0.80(F[0,300]((ppERK/totERK < 0.1) ∧ F[300,600](ppERK/totERK > 0.5)))
Model simulations have shown that a small number of agonist peptides are sufficient for cell activation. Our second
property verifies this behavior by determining if T-cell is able to achieve the active state in the later half of its simulation
provided that it was inactive during the first half.
Property 3:
P≥0.70(F[0,1000]((ppERK/totERK > 0.5) ∧ F[1000,2000](ppERK/totERK < 0.1)))
It is known that cell activation achieved by agonist peptides (Property 2) can be almost completely inhibited by
antagonist peptides [38]. The third property monitors the deactivation behavior of T-cells which is a result of pSHP
mediated negative feedback. This property verifies if the system can go from an active state during first 300 seconds of
the simulation to an inactive state during the next 300 seconds. Figure 3 illustrates the successful as well as unsuccessful
traces of T-cell model obtained from BioNetGen against the above three STL properties.
Table 2 shows the estimated set of parameter values of the same model satisfying all three probabilistic specifications
simultaneously obtained by BioMETA when α = 0.005, β = 0.2 and r = {0.85, 0.80, 0.70}. In Table 2, the first eight
parameters represent the molecules present in T-cell model with their respective initial concentrations. Parameters
9-29 are the rate constants which quantify the rate of reaction rules. All three properties validated for this model
involve the monitoring of doubly phosphorylated ERK (ppERK). The rate constants involved in the phosphorylation
and dephosphorylation of ERK are parameter 28 (e1) and 29 (e2) respectively.
6 Conclusions and Future Work
In this study, we introduce a new approach for estimating the parameters of a rule-based stochastic biochemical model
such that the model is able to satisfy multiple probabilistic temporal logic behavioral specifications simultaneously.
Our proposed method BioMETA is based on merging a multiple hypothesis testing based statistical model checking
approach with a simulated annealing based search to find a single set of parameter values for the model so that the
model satisfies all the given probabilistic temporal logic behavioral specifications. Our experimental results demonstrate
that BioMETA was successful in estimating 26 and 29 parameters of two rule-based biochemical models FcRI and
T-cell respectively against three probabilistic temporal logic behavioral specifications each.
We plan to pursue multiple directions for future work. Our current method requires several sequential model simulations
to be generated in order to check model satisfiability; therefore, we plan to take advantage of the latest parallel
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Figure 3: Successful simulation trajectories (in blue) of T-cell model satisfying property 1, 2 and 3. Unsuccessful
trajectories against each of the above properties are shown in red.
Table 2: Estimated set of parameter values obtained by BioMETA for T-cell model satisfying three specifications with
r = {0.85, 0.80, 0.70}, α = 0.005, β = 0.2
Param No. Param Name Param Value
1 pMHC(p∼ag) 2380.744
2 pMHC(p∼en) 1.984e05
3 TCR 170.82
4 LCK 9.002e05
5 ZAP 1.121e06
6 MEK 7.734e05
7 ERK 63578.59
8 SHP 2681.37
9 b1 0.000103
10 b2 0.000269
11 d1 0.8554
12 d2 244.886
13 lb 8.76e-09
14 ly1 1.90e-06
15 ly2 2.6903
16 ls1 0.0025
17 ls2 1.79e-05
18 tp 1.4047
19 s0 3.48e-08
20 s1 0.00107
21 s2 1.22e-06
22 s3 0.000113
23 z0 0.000121
24 z1 0.00168
25 z2 1.52572
26 m1 0.000504
27 m2 0.38002
28 e1 1.32e-05
29 e2 0.5078
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computing frameworks and execute these simulations in parallel by implementing the presented algorithm on GPUs.
The curse of dimensionality is one of the biggest challenges faced when designing solutions to such problems. To
address this, we intend to investigate dimensionality reduction techniques [39] which would help the search process to
perform more efficiently and generate useful results faster.
We are also interested in exploring and designing solutions based on deep learning techniques that can improve the
search process. Another interesting future direction is to construct a neural network that is able to learn the given
biochemical model from its BioNetGen simulation traces. Later this neural network could be used to generate hundreds
of simulation traces in parallel on GPUs eliminating the need to actually simulate the model. This could eventually help
expedite the parameter estimation process.
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